MedPath

NEUROTROPE BIOSCIENCE INC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:0
Completed:3

Trial Phases

2 Phases

Phase 1:1
Phase 2:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 2
3 (75.0%)
Phase 1
1 (25.0%)

Bryostatin Treatment of Moderately Severe Alzheimer's Disease

Phase 2
Completed
Conditions
Alzheimer Disease
Interventions
Other: Placebo
First Posted Date
2020-09-03
Last Posted Date
2024-07-31
Lead Sponsor
Neurotrope Bioscience, Inc.
Target Recruit Count
122
Registration Number
NCT04538066
Locations
🇺🇸

Axiom Research, Colton, California, United States

🇺🇸

Pacific Research Network, San Diego, California, United States

🇺🇸

JEM Research, Atlantis, Florida, United States

and more 16 locations

A Study of Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine

Phase 2
Completed
Conditions
Alzheimer Disease
Interventions
Other: Placebo
First Posted Date
2018-06-18
Last Posted Date
2020-10-01
Lead Sponsor
Neurotrope Bioscience, Inc.
Target Recruit Count
108
Registration Number
NCT03560245
Locations
🇺🇸

Neuro Pain Medical Center, Fresno, California, United States

🇺🇸

Nader Pharmacology Research Institute, Los Alamitos, California, United States

🇺🇸

Syrentis Clinical Research, Santa Ana, California, United States

and more 24 locations

A Study Assessing Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease

Phase 2
Completed
Conditions
Alzheimer's Disease
Interventions
Other: Placebo
First Posted Date
2015-05-01
Last Posted Date
2018-07-06
Lead Sponsor
Neurotrope Bioscience, Inc.
Target Recruit Count
147
Registration Number
NCT02431468
Locations
🇺🇸

Xenoscience, Inc/ 21st Century Neurology, Phoenix, Arizona, United States

🇺🇸

ATP Clinical Research, Inc., Costa Mesa, California, United States

🇺🇸

Nader Pharmacology Research Institute, Los Alamitos, California, United States

and more 26 locations

Study to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's Disease

Phase 1
Terminated
Conditions
Alzheimer's Disease
Interventions
Drug: Placebo
First Posted Date
2014-08-21
Last Posted Date
2017-11-06
Lead Sponsor
Neurotrope Bioscience, Inc.
Target Recruit Count
9
Registration Number
NCT02221947
Locations
🇺🇸

California Clinical Trials Medical Center, Glendale, California, United States

News

No news found
© Copyright 2025. All Rights Reserved by MedPath